title: Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
authors.affiliation: Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.|Department of Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA. mark.gonzalez@choa.org.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Gonzalez
authors.affiliation: Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Allison R
authors.initials: AR
authors.lastname: McMullen
authors.affiliation: Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Meghan A
authors.initials: MA
authors.lastname: Wallace
authors.affiliation: Pharmacy Department, Barnes-Jewish Hospital, St. Louis, MO, USA.|Department of Pharmacy, Methodist Dallas Medical Center, Dallas, TX, USA.
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Crotty
authors.affiliation: Pharmacy Department, Barnes-Jewish Hospital, St. Louis, MO, USA.|Pharmacy Practice Department, St. Louis College of Pharmacy, St. Louis, MO, USA.
authors.forename: David J
authors.initials: DJ
authors.lastname: Ritchie
authors.affiliation: Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Carey Ann D
authors.initials: CA
authors.lastname: Burnham
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D053961:Azabicyclo Compounds / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics; D002442:Ceftazidime / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000235:genetics / Q000378:metabolism; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D060888:Real-Time Polymerase Chain Reaction; D000078142:Tazobactam
chemical_list: D000900:Anti-Bacterial Agents; D053961:Azabicyclo Compounds; D001426:Bacterial Proteins; D002511:Cephalosporins; D004269:DNA, Bacterial; D004338:Drug Combinations; C000595613:avibactam, ceftazidime drug combination; C000594038:ceftolozane, tazobactam drug combination; D010397:Penicillanic Acid; D002442:Ceftazidime; D000078142:Tazobactam